Canakinumab Efficacy Confirmed In Recurrent Fever Disorders Canakinumab Efficacy Confirmed In Recurrent Fever Disorders

Canakinumab controlled flares in colchicine-resistant familial Mediterranean fever, mevalonate kinase deficiency, and tumor necrosis factor receptor-associated periodic syndrome.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Rheumatology News Source Type: news